Dental Membrane and Bone Graft Substitutes Market to rise to US$ 922.6 Million by 2024

Transparency Market Research notes that innovation and expansion into emerging regions have served these companies well in strengthening their hold in the dental membrane and bone graft substitutes market. For instance, Switzerland-based Geistlich Pharma AG - a global manufacturer and supplier of dental products and devices - expanded its operations in Sydney, Australia and New Delhi, India in 2016.

The global dental membrane and bone graft substitutes market is expected to rise from a value of US$419 mn in 2015 to US$922.6 mn by 2024. If these values hold true, the market is expected to exhibit a strong CAGR of 9.3% during the forecast period.

Read Report Overview @ https://www.transparencymarketresearch.com/dental-membrane-bone-graft-substitutes-market.html

Bone graft substitutes formed the leading product segment, accounting for a whopping 94.8% market share in 2015. Xenograft was the dominant sub-segment in 2015. Dental membranes, however, are expected to register a CAGR of 10.1% from 2016 to 2024, emerging as a highly lucrative investment option. By material, human cells sources hold the dominant share, while collagen is projected to witness strong growth in the near future.

Dental clinics are the leading as well as most promising end users of dental membranes and bone graft substitutes. Europe held the major share of 27.8% in the dental membrane and bone graft substitutes market in 2016. Asia Pacific, on the other hand, is projected to be a rapidly growing market, registering a CAGR of 11.0% from 2016 to 2024.

The rapid growth of dental tourism across developing countries such as Hungary, Mexico, China, and India has resulted in the availability of cost-effective and quality dental services. Healthy Travel Media, a leading publishing house in the U.S., finds that developing nations offer dental services at a cost that is 50% to 80% lower than that in developed countries such as the U.S. This has resulted in a surge in dental procedures across the globe, thereby fueling the demand for dental membranes and bone graft substitutes.

“Innovation in bone graft techniques is also a key factor driving this market,” the author of the study says. Advanced techniques such as xenograft and demineralized bone matrix have gained preference among patients in recent times owing to the several benefits they offer. Bone grafting is a procedure performed to replace a missing bone in a patient. Ideally, bone grafts are autologous, which means that the bone is harvested from the patient’s own body. This can be an extremely complex and risky procedure. Moreover, there is an acute shortage of donors. The development of xenografts allows bone substitutes to be taken from non-human species, such as bovine or natural coral, which addresses this shortage and also serves as a preferred options for people suffering from heart and kidney ailments.

Request Sample Report @ https://www.transparencymarketresearch.com/sample/sample.php?flag=S&rep_id=16340

The global market for dental membrane and bone graft substitutes is rather fragmented, with the top four companies accounting for 30.0% in 2015. DENTSPLY International, Inc., Zimmer Biomet Holdings, Inc., Institut Straumann AG, and Integra LifeSciences Holdings Corporation presently dominate the global scene.

About TMR

Transparency Market Research (TMR) is a market intelligence company, providing global business information reports and services. Our exclusive blend of quantitative forecasting and trends analysis provides forward-looking insight for thousands of decision makers. TMR’s experienced team of analysts, researchers, and consultants, use proprietary data sources and various tools and techniques to gather, and analyze information. Our business offerings represent the latest and the most reliable information indispensable for businesses to sustain a competitive edge.

Each TMR syndicated research report covers a different sector - such as pharmaceuticals, chemicals, energy, food & beverages, semiconductors, med-devices, consumer goods and technology. These reports provide in-depth analysis and deep segmentation to possible micro levels. With wider scope and stratified research methodology, TMR’s syndicated reports strive to provide clients to serve their overall research requirement.

US Office Contact

90 State Street, Suite 700
Albany, NY 12207
Tel: +1-518-618-1030
USA - Canada Toll Free: 866-552-3453
Email: sales@transparencymarketresearch.com
Website: http://www.transparencymarketresearch.com/

This release was published on openPR.